Cargando…
REV7 confers radioresistance of esophagus squamous cell carcinoma by recruiting PRDX2
Radiotherapy has been widely used for the clinical management of esophageal squamous cell carcinoma. However, radioresistance remains a serious concern that prevents the efficacy of esophageal squamous cell carcinoma (ESCC) radiotherapy. REV7, the structural subunit of eukaryotic DNA polymerase ζ, h...
Autores principales: | Gu, Cheng, Luo, Judong, Lu, Xujing, Tang, Yiting, Ma, Yan, Yun, Yifei, Cao, Jianping, Cao, Juhua, Huang, Zeyu, Zhou, Xifa, Zhang, Shuyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398896/ https://www.ncbi.nlm.nih.gov/pubmed/30657231 http://dx.doi.org/10.1111/cas.13946 |
Ejemplares similares
-
Downregulation of ubiquitin inhibits the proliferation and radioresistance of non-small cell lung cancer cells in vitro and in vivo
por: Tang, Yiting, et al.
Publicado: (2015) -
Expression of YY1 correlates with progression and metastasis in esophageal squamous cell carcinomas
por: Luo, Judong, et al.
Publicado: (2014) -
OTUD5 Regulates p53 Stability by Deubiquitinating p53
por: Luo, Judong, et al.
Publicado: (2013) -
Overexpression of Peroxiredoxin 6 (PRDX6) Promotes the Aggressive Phenotypes of Esophageal Squamous Cell Carcinoma
por: He, Yan, et al.
Publicado: (2018) -
DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer
por: Ou, Yao, et al.
Publicado: (2018)